Endocrine Neoplasms

  • Andrew Arnold

Part of the Cancer Treatment and Research book series (CTAR, volume 89)

Table of contents

  1. Front Matter
    Pages i-xiv
  2. Giovanni Cizza, George P. Chrousos
    Pages 25-40
  3. Laurence Katznelson, Anne Klibanski
    Pages 41-55
  4. Stefan K. G. Grebe, Ian D. Hay
    Pages 91-140
  5. Arthur B. Schneider, Leon Fogelfeld
    Pages 141-161
  6. Kerstin Sandelin
    Pages 183-192
  7. David Goltzman, Janet E. Henderson
    Pages 193-215
  8. Ana C. Latronico, George P. Chrousos
    Pages 217-237
  9. William F. Young Jr.
    Pages 239-261
  10. Richard T. Kloos, Melvyn Korobkin, Norman W. Thompson, Isaac R. Francis, Brahm Shapiro, Milton D. Gross
    Pages 263-292
  11. Robert T. Jensen
    Pages 293-334
  12. F. John Service
    Pages 335-346
  13. Pamela M. Thomas, Gilbert J. Cote
    Pages 347-363
  14. Norman W. Thompson
    Pages 407-419
  15. Back Matter
    Pages 443-450

About this book


Andrew Arnold The past several years have been a time of intense excitement and have brought major advances in the understanding and treatment of endocrine neoplasms. This is therefore an excellent point at which to undertake a broad­ based overview of the state of the art in endocrine neoplasia for the Cancer Treatment and Research series. Because of the wide and interdisciplinary readership of this series, our aim for each chapter has been to provide ample background for those not highly familiar with the topic, while emphasizing the most recent advances. Furthermore, the chapters have been written with the clinician in mind, whether she or he is an oncologist, endocrinologist, surgeon, generalist, pathologist, or radiologist. As such, the authors' mission has been to focus on clinically relevant issues and to present the scientific basis of current or potential future advances in a manner easily digestible to the nonexpert. Endocrine tumors often cause problems for the patient by virtue of their hormonal activity, which may frequently (but certainly not always) over­ shadow the adverse consequences related to their mass per se. In fact, it is important to keep in mind that endocrine tumors can manifest two biologically separable but often intertwined properties, namely, increased cell mass and abnormal hormonal function. These need not go hand in hand, and their distinction has definite clinical relevance in, for example, the increasingly recognized problem of incidentally discovered adrenal or pituitary masses.


Tumor cancer treatment carcinoma diagnosis genetics hormones pathogenesis screening tumorigenesis

Editors and affiliations

  • Andrew Arnold
    • 1
  1. 1.Laboratory of Endocrine Oncology Massachusetts General HospitalHarvard Medical SchoolBostonUSA

Bibliographic information

  • DOI
  • Copyright Information Kluwer Academic Publishers 1997
  • Publisher Name Springer, Boston, MA
  • eBook Packages Springer Book Archive
  • Print ISBN 978-1-4613-7919-5
  • Online ISBN 978-1-4615-6355-6
  • Series Print ISSN 0927-3042
  • Buy this book on publisher's site